Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Genome plasticity of BCG and impact on vaccine efficacy.

Brosch R, Gordon SV, Garnier T, Eiglmeier K, Frigui W, Valenti P, Dos Santos S, Duthoy S, Lacroix C, Garcia-Pelayo C, Inwald JK, Golby P, Garcia JN, Hewinson RG, Behr MA, Quail MA, Churcher C, Barrell BG, Parkhill J, Cole ST.

Proc Natl Acad Sci U S A. 2007 Mar 27;104(13):5596-601.

2.

[Efficacy and safety of vaccines against tuberculosis in the relation to genetic variability of Mycobacterium bovis BCG strains].

Prygiel M, Janaszek-Seydlitz W, Bucholc B.

Przegl Epidemiol. 2011;65(4):621-8. Review. Polish.

PMID:
22390050
3.

Recombinant BCG as a vaccine vehicle to protect against tuberculosis.

Triccas JA.

Bioeng Bugs. 2010 Mar-Apr;1(2):110-5. doi: 10.4161/bbug.1.2.10483. Review.

4.

Recombinant BCG vaccine candidates.

Hernàndez-Pando R, Castañòn M, Espitia C, Lopez-Vidal Y.

Curr Mol Med. 2007 Jun;7(4):365-72. Review.

PMID:
17584076
5.

Correlation between BCG genomics and protective efficacy.

Behr MA.

Scand J Infect Dis. 2001;33(4):249-52. Review.

PMID:
11345214
6.

BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy.

Liu J, Tran V, Leung AS, Alexander DC, Zhu B.

Hum Vaccin. 2009 Feb;5(2):70-8. Review.

PMID:
19164935
7.

Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developments.

Dietrich G, Viret JF, Hess J.

Vaccine. 2003 Jan 30;21(7-8):667-70. Review.

PMID:
12531337
8.

Comparative genomics of BCG vaccines.

Behr MA.

Tuberculosis (Edinb). 2001;81(1-2):165-8. Review.

PMID:
11463238
9.

Recombinant live vaccine candidates against tuberculosis.

Kaufmann SH, Gengenbacher M.

Curr Opin Biotechnol. 2012 Dec;23(6):900-7. doi: 10.1016/j.copbio.2012.03.007. Review.

PMID:
22483201
10.

[Novel vaccines against M. tuberculosis].

Okada M.

Kekkaku. 2006 Dec;81(12):745-51. Review. Japanese.

PMID:
17240920
11.

Novel vaccination strategies based on recombinant Mycobacterium bovis BCG.

Dietrich G, Viret JF, Hess J.

Int J Med Microbiol. 2003 Feb;292(7-8):441-51. Review.

PMID:
12635927
12.

Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree.

Oettinger T, Jørgensen M, Ladefoged A, Hasløv K, Andersen P.

Tuber Lung Dis. 1999;79(4):243-50. Review.

PMID:
10692993
13.

BCG Vaccines.

Tran V, Liu J, Behr MA.

Microbiol Spectr. 2014 Feb;2(1):MGM2-0028-2013. doi: 10.1128/microbiolspec.MGM2-0028-2013. Review.

PMID:
26082111
14.
15.

Recombinant Mycobacterium bovis BCG.

Bastos RG, Borsuk S, Seixas FK, Dellagostin OA.

Vaccine. 2009 Nov 5;27(47):6495-503. doi: 10.1016/j.vaccine.2009.08.044. Review.

PMID:
19720367
16.

[When will the new tuberculosis vaccine appear?].

Koroliuk AM, Zazimko LA, Petrovskiĭ SV.

Zh Mikrobiol Epidemiol Immunobiol. 2015 Jan-Feb;(1):86-94. Review. Russian.

PMID:
25842959
17.

The use of mutant mycobacteria as new vaccines to prevent tuberculosis.

Hernàndez Pando R, Aguilar LD, Infante E, Cataldi A, Bigi F, Martin C, Gicquel B.

Tuberculosis (Edinb). 2006 May-Jul;86(3-4):203-10. Review.

PMID:
16542875
18.

Genomics of Mycobacterium bovis.

Gordon SV, Eiglmeier K, Garnier T, Brosch R, Parkhill J, Barrell B, Cole ST, Hewinson RG.

Tuberculosis (Edinb). 2001;81(1-2):157-63. Review.

PMID:
11463237

Supplemental Content

Support Center